18 August 2022
A synthesis of emerging evidence in inflammatory arthritis
Clinical updates based on the Australian living guidelines for inflammatory arthritis and developed and informed by feedback from specialists are now available.
This is an opportunity for rheumatologists to discuss the latest evidence around treatment including conventional, biological and targeted synthetic DMARDs, highlighting both gaps and uncertainties in evidence, as well as best practice and the latest guidelines.
Updates are provided in a 30-minute face to face discussion which can take place at your practice or via zoom at a time convenient for you.
This is a non-commercial service available through Australian Government Department of Health through the Value in Prescribing bDMARDs Program Grant. Updates are facilitated by NPS MedicineWise